NEW YORK (GenomeWeb News) - Bruker BioSciences’ shares bolted up 19.5 percent today following this morning’s announcement that it is buying its affiliate Bruker BioSpin for $914 million in cash and stock.
In afternoon trading, Bruker’s shares had risen $1.87 to $11.16.
Bruker BioSpin makes magnetic resonance core technology. It posted $447 million in revenue and $56.6 million in net income in 2006.
The combined firm expects to have 2007 pro forma revenue of more than $900 million.